» Articles » PMID: 26770385

In Vitro, Ex Vivo and in Vivo Anti-hypertensive Activity of Chrysophyllum Cainito L. Extract

Overview
Specialty General Medicine
Date 2016 Jan 16
PMID 26770385
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Chrysophyllum cainito L., a traditional herbal medicine, could have the potential for management of hypertension due to presence of polyphenolic compounds. The extracts and fractions of the pulp of plant were evaluated for in vitro (inhibition of angiotensin I converting enzyme/ACE assay), ex vivo (isolated aorta relaxation assay) and in vivo (salt induced hypertensive rat assay). The alcoholic and aqueous extract (ALE and AQE respectively) of fruit of plant C. cainito was having 14.8 and 9.2% yield respectively. The fractionation with ethyl alcohol (EAF) and butanol (BTF) yielded 2.52 & 2.17% respectively from ALE and 0.46 & 0.31% respectively from AQE with respect to fruit pulp dry weight. More phenolic content was found in ALE (3.75±0.15 mg gallic acid equivalent or GAE g(-1) of dry power of fruit pulp) compared to AQE and maximum in ethyl acetate fraction of ALE (ALE-EAF) (2.32±0.21 mg GAE g(-1) of dry power of fruit pulp) among all fractions. ACE inhibition activity was found to be maximum in ALE-EAF 62.5±7.34%. While ex vivo study using isolated tissue of aorta showed again showed maximum activity (62.82±6.19 and 46.47±8.32% relaxation with 50 µg mL(-1) and 10 µg mL(-1) GAE concentration respectively). ALE-EAF reduced the elevated arterial pressure of salt induced hypertensive rat significantly to the level of normotensive animal group. Results of ALE-EAF have shown its potential as a source for novel constituent for the treatment hypertension and should further be studied for isolation of specific constituent for more effectiveness.

Citing Articles

Bio-Guided Extraction of a Phenolic-Rich Extract from Industrial Peanut Skin with Antioxidant and Hypotensive Potential.

de Matos A, Batista D, Pinheiro L, de Matuoka E Chiocchetti G, Berni P, Alves Macedo G Foods. 2024; 13(21).

PMID: 39517194 PMC: 11545112. DOI: 10.3390/foods13213410.


Effect of Enzymatic Biotransformation on the Hypotensive Potential of Red Grape Pomace Extract.

Batista D, de Matuoka E Chiocchetti G, Macedo J Foods. 2023; 12(22).

PMID: 38002167 PMC: 10670604. DOI: 10.3390/foods12224109.


Phenolic Compounds in Mesoamerican Fruits-Characterization, Health Potential and Processing with Innovative Technologies.

Gomez-Maqueo A, Escobedo-Avellaneda Z, Welti-Chanes J Int J Mol Sci. 2020; 21(21).

PMID: 33171785 PMC: 7664671. DOI: 10.3390/ijms21218357.


Development of a Multifunction Set Yogurt Using S. Lee (Chinese Sweet Tea) Extract.

Abdel-Hamid M, Huang Z, Suzuki T, Enomoto T, Hamed A, Li L Foods. 2020; 9(9).

PMID: 32846883 PMC: 7555928. DOI: 10.3390/foods9091163.


Design and optimization of candesartan loaded self-nanoemulsifying drug delivery system for improving its dissolution rate and pharmacodynamic potential.

Verma R, Kaushik D Drug Deliv. 2020; 27(1):756-771.

PMID: 32397771 PMC: 7269045. DOI: 10.1080/10717544.2020.1760961.


References
1.
Dhamija I, Kumar N, Manjula S, Parihar V, Setty M, Pai K . Preliminary evaluation of in vitro cytotoxicity and in vivo antitumor activity of Premna herbacea Roxb. in Ehrlich ascites carcinoma model and Dalton's lymphoma ascites model. Exp Toxicol Pathol. 2011; 65(3):235-42. DOI: 10.1016/j.etp.2011.08.009. View

2.
Kwon Y, Apostolidis E, Shetty K . In vitro studies of eggplant (Solanum melongena) phenolics as inhibitors of key enzymes relevant for type 2 diabetes and hypertension. Bioresour Technol. 2007; 99(8):2981-8. DOI: 10.1016/j.biortech.2007.06.035. View

3.
Ademiluyi A, Oboh G . Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro. Exp Toxicol Pathol. 2011; 65(3):305-9. DOI: 10.1016/j.etp.2011.09.005. View

4.
Rishton G . Natural products as a robust source of new drugs and drug leads: past successes and present day issues. Am J Cardiol. 2008; 101(10A):43D-49D. DOI: 10.1016/j.amjcard.2008.02.007. View

5.
Wijesekara I, Kim S . Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry. Mar Drugs. 2010; 8(4):1080-93. PMC: 2866476. DOI: 10.3390/md8041080. View